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Abstract
Neurodegenerative diseases, including Alzheimer’s disease, are characterized by a progressive and selective loss of neurons. Apoptosis
under mitochondrial control has been implicated in this neuronal death process, involving the release of cytochrome c into the cytoplasm
and initiation of the apoptosis cascade. However, a growing body of evidence suggests an active role for the endoplasmic reticulum in
regulating apoptosis, either independent of mitochondrial, or in concert with mitochondrial-initiated pathways. Members of the Bcl-2
family of proteins have been shown to either inhibit apoptosis, as is the case with Bcl-2, or to promote it, in the case of Bax.
Investigations in our laboratory have focused on neuronal injury resulting from the intracisternal administration of aluminum maltolate to
New Zealand white rabbits, an animal system relevant to a study of human disease in that it reflects many of the histological and
biochemical changes associated with Alzheimer’s disease. Here we report that treatment of young adult rabbits with aluminum maltolate
induces both cytochrome c translocation into brain cytosol, and caspase-3 activation. Furthermore, as assessed by Western blot analysis,
these effects are accompanied by a decrease in Bcl-2 and an increase in Bax reactivity in the endoplasmic reticulum.  2001 Elsevier
Science B.V. All rights reserved.
Theme: Disorder of the nervous system
Topic: Neurotoxicity
Keywords: Bcl-2; Bax; Mitochondria; Endoplasmic reticulum; Alzheimer’s disease; Aluminum

1. Introduction
Apoptosis, which plays a critical role in the normal
development and maintenance of tissue homeostasis, plays
an important role in neurodegenerative diseases and aging
[26]. Alzheimer’s disease, a common neurodegenerative
disorder, is characterized typically by intraneuronal neurofibrillary tangles, neuritic plaques and selective neuronal
death, with evidence of apoptosis being observed as an
*Corresponding author. Tel.: 11-804-924-5682; fax: 11-804-9245718.
E-mail address: js2r@virginia.edu (J. Savory).

early event preceding the formation of these classical
neuropathological features [32]. Mitochondrial changes
following cytotoxic stimuli represent a primary event in
apoptotic cell death, since the apoptogenic factor, cytochrome c, is released into the cytoplasm [2,15,20,21].
Once this translocation occurs, cytochrome c binds to
another cytoplasmic factor, Apaf-1, and the formed complex activates the initiator caspase-9 that in turn activates
the effector caspases, of which caspase-3 is a prominent
member [17,31]. Release of cytochrome c from the
mitochondria has been shown to involve two distinct
pathways. One implicates the opening of the mitochondria
permeability transition pore (MTP), and the second, trig-
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gered by the proapoptogenic Bax, is independent of the
MTP opening [6]. While Bax has been shown to trigger
cell death [7,35], the antiapoptotic Bcl-2 can block cytochrome c release and caspase activation [1,25]. Bcl-2
resides in the mitochondria and prevents activation of the
effector caspases by mechanisms such as blockade of the
MTP opening [19,30], or by functioning as a docking
protein [24].
Although Bcl-2 may have a direct action on the mitochondria, it also resides in the endoplasmic reticulum
[4,36]. A growing body of evidence suggests an active role
for the endoplasmic reticulum in the regulation of apoptosis. Indeed, stress in the endoplasmic reticulum has been
shown to induce apoptosis [34] and, furthermore, the
endoplasmic reticulum induces activation of caspase-12, an
effect not triggered by mitochondrial stress [22]. Recently,
it has been reported that the drug brefeldin induces
endoplasmic reticulum dilatation and leads to cytochrome
c release and caspase-3 activation [8]. This effect was
blocked by the wild-type Bcl-2 and, surprisingly, a Bcl-2
variant that is exclusively targeted to the endoplasmic
reticulum, was also able to accomplish the same task [8].
The authors suggested the existence of ‘cross-talk’ under
Bcl-2 control between the endoplasmic reticulum and
mitochondria, and that Bcl-2 may exert its protective effect
by controlling calcium homeostasis in the different cell
compartments.
Studies in our laboratory have focused on neuronal
injury resulting from the intracisternal administration of
aluminum (Al) maltolate to New Zealand white rabbits.
This animal system is relevant to a study of human disease
in that it reflects many of the histological and biochemical
changes associated with Alzheimer’s disease [10]. In the
present study we have investigated the effect of Al
maltolate-induced neurotoxic injury on cytochrome c
release and caspase-3 activation in hippocampus of young
adult rabbits. Changes in Bcl-2 and Bax responses in
mitochondria and endoplasmic reticulum were further
assessed to determine whether cross-talk between these
intracellular organelles is also involved in the control of
programmed cell death in this animal system.

2. Material and methods

2.1. Animals and treatment
All animal procedures were in accordance with the US
Public Health Service Policy on Humane Care and Use of
Laboratory Animals, and the National Institutes of Health
Guide for the Care and Use of Laboratory Animals. The
animal protocol was approved by the University of Virginia Animal Care and Use Committee. Young adult (8–12
months old) female New Zealand white rabbits received
either intracisternal injections of 100 ml saline (controls,
n56) or 100 ml of 50 mM Al maltolate in saline (treated,
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n56). Al maltolate is soluble at neutral pH, thus avoiding
precipitation of insoluble Al hydroxide as encountered
with most of other Al compounds used for neurotoxicological studies [29]. The injection was carried out
under ketamine anesthesia according to the method described previously [27]. Al-treated animals and matched
controls were sacrificed on days 2 or 3, depending on the
time required for the development of severe neurological
symptoms in the Al-treated group. Rabbits were euthanized and then perfused with Dulbecco’s phosphate-buffered saline (PBS, Gibco, Grand Island, NY) as described
previously [10,11,28]. Brains were immediately removed
after sacrifice, and a coronal section cut and bisected to
yield two symmetrical hippocampal segments, one for
immunohistochemistry and the other for immunoblot analysis. The respective sides chosen for these studies were
alternated between successive animals. Each brain hemisphere intended for histology was immediately frozen on a
liquid nitrogen-cooled surface, placed into a zipper-closure
plastic bag, and buried in dry ice pellets until transferring
to 2808C before sectioning. For immunoblot analysis,
tissue from the hippocampus was rapidly dissected,
homogenized and subjected to ultracentrifugation as described below.

2.2. Western blot analysis
Proteins from the mitochondrial, cytosolic and endoplasmic fractions were extracted as described previously
[18]. Approximately 100 mg of brain tissue from hippocampus was gently homogenized, using a teflon
homogenizer (Thomas, Philadelphia PA), in seven volumes
of cold suspension buffer (20 mM Hepes–KOH (pH 7.5),
250 mM sucrose, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 2
mg / ml aprotinin, 10 mg / ml leupeptin, 5 mg / ml pepstatin
and 12.5 mg / ml of N-acetyl-Leu-Leu-Norleu-Al). The
homogenates were first centrifuged at 7503g at 48C for 5
min, and then at 80003g for 20 min at 48C. The 80003g
pellets were resuspended in cold buffer without sucrose
and used as the mitochondrial fraction. The supernatant
was further centrifuged at 100 0003g for 60 min at 48C to
separate the cytosolic from the endoplasmic reticulum
fractions. Protein concentrations were determined with the
BCA protein assay reagent (Pierce, Rockford, IL). Proteins
(7.5 mg) from the mitochondrial, cytosolic and endoplasmic fractions were separated by SDS–PAGE (15% gel)
under reducing conditions followed by transfer to a
polyvinylidene difluoride membrane (Millipore) at 30 mA
for 210 min in transfer buffer (20 mM Tris-base, 150 mM
glycine, 20% methanol). Following transfer, membranes
were incubated with mouse monoclonal antibody (mAb) to
human cytochrome c (Pharmingen, San Diego, CA) at a
1:250 dilution, or to a 1:100 dilution of mAbs recognizing
either Bcl-2 or Bax (Santa Cruz Biotechnology, CA).
Cytochrome oxidase subunit IV (COX) mAb obtained
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from a commercial source (Molecular Probes, Eugene,
OR) was used as a marker of mitochondrial contamination
at 1:1000 dilution. A calnexin mAb (Transduction Laboratories, Lexington, MD) was used at 1:500 dilution as an
endoplasmic reticulum marker, and a mAb to anti-b actin
(Sigma, St. Louis, MO) was used at a 1:250 dilution as a
gel loading control. Following washes with Tris-buffered
saline (TBS) containing 0.1% Triton X-100, the blots were
developed using enhanced chemiluminescence (ImmunStar goat anti-mouse IgG detection kit, Bio-Rad, Hercules,
CA). The bands of cytochrome c, Bax and Bcl-2 which had
been developed on radiographic film, were scanned and
densitometrically analyzed using Personal Densitometer SI
and Image Quant 5.0 software (Molecular Dynamics,
Sunnyvale, CA), and these quantitative analyses were
expressed as mean6S.E.M. values. Unpaired Student’s
t-test was used to compare levels of each protein between
controls and Al-treated groups in the same subcellular
fraction.

2.3. Fluorometric assay of caspase-3 activities
Lysates were prepared by homogenizing hippocampal
tissue in 20 mM Hepes–KOH (pH 7.5), 250 mM sucrose,
10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA,
1 mM DTT, 0.1 mM PMSF. Lysates were centrifuged for
30 min at 160 0003g and proteins in the supernatant were
quantified using the Bradford method. Lysates (50 mg
protein) were incubated for 1 h at 378C in 1 ml of 13
Hepes buffer containing 10 ml of the fluorogenic substrate
Ac-DEVD-AMC (Caspase-3 assay kit, Pharmingen, San
Diego, CA). Cleavage of the substrate was monitored at an
excitation wavelength of 380 nm and emission wavelength
of 440 nm using a Model 450 fluorometer (BioMolecular).
Each sample was incubated with or without 10 ml of the
caspase-3 inhibitor Ac-DEVD-CHO (Pharmingen, Saint
Diego, CA). Caspase-3 activity for each sample was
calculated as the difference between the rate of cleavage in
the absence and presence of the inhibitor.

hydrogen peroxide, with light hematoxylin counterstaining.
All procedures were performed at room temperature unless
otherwise noted.

3. Results

3.1. Western blot analysis
To confirm the purity of the subcellular fractions, we
used antibodies against organelle-specific marker proteins;
cytochrome c oxidase for mitochondria and calnexin for
endoplasmic reticulum. As shown in Fig. 1, the fractions
were pure, and the b-actin staining, used as a gel loading
control, shows similar protein loading in all the wells.
The immunoreactivity of cytochrome c is evident as a
single band with a molecular weight of 15 kDa. In
controls, cytochrome c immunoreactivity is not detectable
in the cytosolic fraction, but is strongly positive in the
mitochondrial and endoplasmic fractions (Fig. 2A). In the
Al-treated group, cytochrome c is distributed in the
cytosolic, mitochondrial, and endoplasmic reticulum fractions (Fig. 2B).
The antibody to Bcl-2 identifies a protein band with an
apparent molecular weight of 27 kDa. Bcl-2 is not detected
in the cytoplasmic fractions, but relatively intense bands
are found in the mitochondrial and endoplasmic fractions
in controls (Fig. 2C). In the Al-treated group, Bcl-2 is
restricted to the mitochondria and is barely detected in
either the cytosolic or endoplasmic reticulum fractions
(Fig. 2D). Bax, with an apparent molecular weight of 21
kDa, is distributed in all the fractions, but with a higher
intensity in the cytosolic than in the mitochondrial or
endoplasmic reticulum fractions (Fig. 2E). In the Al-

2.4. Immunohistochemistry
Serial 14-mm thick coronal frozen sections from control
and Al-treated animals were cut at the level of the
hippocampus and stored at 2808C prior to immunostaining. The sections were air-dried at room temperature, fixed
in cold acetone for 10 min, treated with 1% hydrogen
peroxide in PBS and incubated with a blocking solution of
1.5% normal serum, also in PBS. Subsequently, sections
were reacted overnight at 48C with a mouse mAb against
caspase-3 (CPP32, Transduction Laboratories, Lexington,
KY) at a 1:500 dilution. After washing with 50 mM TBS,
and incubating with the biotinylated secondary antibody,
sections were processed with a Vectastain Elite avidin–
biotin complex technique kit (Vector Laboratories, Burlingame, CA) and visualized by 3,39-diaminobenzidine /

Fig. 1. Western blot analysis for b-actin, cytochrome c oxidase subunit
IV (COX) and calnexin in cytoplasmic (c), mitochondrial (m) and
endoplasmic reticulum (er) fractions from control hippocampal lysates.
b-Actin, used as a control loading gel, shows similar protein loading in
the mitochondrial, cytoplasmic and endoplasmic reticulum fractions.
COX, used as a marker for mitochondrial contamination, is only present
in the mitochondrial fractions. Calnexin, used as a marker for the
endoplasmic reticulum, stains only the endoplasmic reticulum fractions.
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Fig. 2. Representative immunoblots for cytochrome c, Bcl-2 and Bax in controls (A,C,E) and in Al-treated groups (B,D,F) in cytoplasmic (c),
mitochondrial (m) and endoplasmic reticulum (er) fractions from hippocampus lysates. (A) Cytochrome c immunoreactivity is not detected in the cytoplasm
but is highly positive in the mitochondria and endoplasmic reticulum in controls. (B) Al treatment induces translocation of cytochrome c into the
cytoplasm, and positive immunoreactivity for cytochrome c is also detected in the mitochondria and endoplasmic reticulum. (C) Bcl-2 staining, which is
not detected in the cytoplasm, is highly positive in the mitochondrial and endoplasmic reticulum fractions. (D) Following Al treatment, Bcl-2 is decreased
in the mitochondria and is barely detectable in the endoplasmic reticulum. (E) Bax is present in the cytoplasm as well as the mitochondria and endoplasmic
reticulum in controls. (F) In the Al-treated group, Bax immunoreactivity is slightly decreased in the cytoplasm and increased in the mitochondria and
endoplasmic reticulum.

treated animals, Bax immunoreactivity is detectable also in
all the fractions; relative amounts are: endoplasmic
reticulum.mitochondria.cytosol (Fig. 2F). The results of
the densitometric analysis of cytosolic, mitochondrial and
endoplasmic reticulum cytochrome c, Bcl-2 and Bax in
controls and Al-treated rabbits, are shown in Table 1.
Cytochrome c is absent in the cytoplasm of controls and its
intensities in the other fractions are mitochondria.
endoplasmic reticulum. Following Al treatment, cytochrome c is distributed as following, cytoplasm5
mitochondria.endoplasmic reticulum. In controls, Bcl-2 is
not present in the cytoplasmic fraction and levels in the
other fractions are mitochondria.endoplasmic reticulum.
In the Al-treated group, Bcl-2 is slightly decreased in the
mitochondria and barely present in the endoplasmic reticulum. In controls, Bax is present in the three subcellular
fractions as follows: cytoplasm.endoplasmic reticulum.
mitochondria. Following the administration of Al maltolate
the distribution of Bax is endoplasmic reticulm.
mitochondria.cytoplasm.

3.2. Caspase-3 activity
The activity of caspase 3-like proteases as assessed by
measuring the cleavage of the fluorogenic substrate AcDEVD-AMC, demonstrates significant elevations in Altreated animals approaching 5-fold greater levels than in
the controls (Fig. 3).

3.3. Immunohistochemistry
The immunohistochemical localization of caspase-3 in
the pyramidal cell layer of the hippocampus of all animals
was examined (Fig. 4A). No reaction for caspase-3 is
observed in sections processed without incubation with
primary antibody (data not shown), or in sections from
untreated animals (Fig. 4B). In brains from Al-treated
rabbits, there is marked positive immunostaining for
caspase-3 in the pyramidal cell layers of the hippocampus
(Fig. 4C, arrows).
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Table 1
Densitometric scanning analysis of cytochrome c, Bcl-2 and Bax in the
cytoplasm, mitochondria and endoplasmic reticulum of controls (n56)
and of Al-treated rabbits (n56)
Cytoplasm

Mitochondria

Endoplasmic
reticulum

Cytochrome c
Controls
Al-treated

–
1.7560.16

2.060.15
1.7560.22

1.6060.18
0.8560.11

Bcl-2
Controls
Al-treated

–
–

1.5060.10
1.1060.08

1.2960.16**
0.1160.06**

Bax
Controls
Al-treated

1.6160.22*
0.9660.18*

0.7260.13
1.0060.10

1.0260.08*
1.4260.23*

While cytochrome c is not detectable in the cytoplasm of controls, it is
released into the cytosol following Al treatment. Bcl-2 resides in the
mitochondria and endoplasmic reticulum in controls; Al treatment
decreases Bcl-2 levels in the endoplasmic reticulum. Bax is distributed in
the cytoplasm.endoplasmic reticulum.mitochondria in controls. Following Al administration, Bax is redistributed in the cytoplasm,
mitochondria,endoplasmic reticulum.
–, undetectable levels. Data are expressed as mean6S.D. *P,0.05;
**P,0.01 (Student’s t-test).

4. Discussion
The current study provides evidence that neurotoxic
injury, induced in rabbits by the intracisternal administration of Al-maltolate, results in cytoplasmic cytochrome c
translocation, endoplasmic reticulum Bcl-2 down-regulation and Bax up-regulation, as well as caspase-3 activation.
In a previous report from our laboratory [29] we presented
immunohistochemical evidence for a similar decrease in
the Bcl-2:Bax ratio, together with evidence of apoptosis, in
aged rabbits treated with Al maltolate, but this effect was

Fig. 3. Caspase-3 activity is shown in hippocampal lysates of controls
(white bar) and Al-treated animals (black bar). In controls, low caspase-3
activity is detected. Al treatment induces a 5.5-fold increase in the
caspase-3 activity. Data are presented as mean6S.E.M.

not observed in young adult animals. In the present study,
by using a higher concentration of Al maltolate, we now
report a dramatic effect following Al administration in
young rabbits. There is considerable support for mitochondria playing a key role in the process of cell death,
with much attention being focused on cytochrome c. When
released into the cytoplasm, cytochrome c forms a complex with the cytosolic molecule Apaf-1 and activates
caspase-9 [33,39]. Subsequently, this complex triggers the
activation of effector caspases, in particular caspase-3 [17].
Release of cytochrome c from mitochondria into the
cytosol has been reported following brain injury in mice
[21] and addition of the the parkinsonian neurotoxin
MPP1 to isolated brain mitochondria [2]. The mechanism
by which cytochrome c is released from mitochondria to
the cytosol is unclear. It has been suggested that following
cytotoxic stimuli, the MTP opens and rapidly causes
depolarization, uncoupling of oxidative phosphorylation,
and subsequent pronounced mitochondrial swelling. Subsequent events are the diffusion of cytochrome c into the
cytosol through the MTP from its location between the
inner and outer mitochondrial membranes [19,38]. On the
other hand, cytochrome c may also translocate from
mitochondria into the cytosol but by a mechanism distinct
from the opening of the MTP. Indeed, it has been shown
that the pro-apoptotic Bax is able to trigger the release of
cytochrome c from isolated mitochondria, and that this
cytochrome c release is not blocked by inhibitors of the
MTP opening [6]. Furthermore, it has been reported, in
staurosporine-induced apoptosis of HeLa cells, that Bid, a
BH3 domain-containing protein, translocates from the
cytosol to mitochondria and binds to Bax. This direct
binding of Bid to Bax is a prerequisite for Bax structural
changes and subsequent cytochrome c release [5]. Our
results show that following Al-maltolate treatment, Bax is
redistributed to be present at higher levels in endoplasmic
reticulum and mitochondria than in the cytosol. Changes in
Bax distribution may then initiate cytochrome c release
and caspase-3 activation. However, whether the cytochrome c release we report here results from opening of
the MTP, or from an alternate pathway, remains to be
determined.
Another interesting finding is the observation of decreased positivity of the anti-apoptotic protein, Bcl-2, in
the endoplasmic reticulum following Al treatment. This
protein is considered to be a key factor regulating apoptosis. It has been shown that Bcl-2-deficient mice underwent fulminant apoptosis of lymphoid tissue in the thymus
and spleen, while mice overexpressing Bcl-2 demonstrated
extended cell survival [13]. In other studies of cells treated
with staurosporine, overexpression of Bcl-2 has been
demonstrated to prevent the efflux of cytochrome c from
the mitochondria and subsequent initiation of apoptosis
[37]. In a cell-free apoptosis system, Bcl-2 over-expression
has also been reported to prevent both the release of
cytochrome c from mitochondria and activation of cas-
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Fig. 4. Immunohistochemical localization of caspase-3 was examined in the pyramidal cell layer of the hippocampus (A, rectangular box). (B) Pyramidal
cell layer of controls shows no immunoreactivity for caspase-3 (3400). (C) Positive immunoreactivity for caspase-3 (arrows) in the pyramidal cell layer in
Al-treated animals (3400). Bar in (C)525 mm.
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pases [12]. Bcl-2 has also been found to prolong the life of
rat neurons subjected to ischemia [3] in haloperidol-induced neuronal death in the hippocampus of mice [16], and
in a transgenic mouse model of familial amyotrophic
lateral sclerosis [14].
As we report here, the ratio of Bcl-2:Bax could be a key
determining factor in the release of cytochrome c, the
activation of caspase-3 and in the initiation of apoptosis,
since these events are accompanied by an up-regulation of
the pro-apoptotic Bax and a down-regulation of the antiapoptotic Bcl-2. Furthermore, as the changes we observed
for Bcl-2 and Bax mainly were in the endoplasmic
reticulum, we suggest that the Bcl-2:Bax ratio in this
cellular organelle regulates the extent of apoptosis. A
decrease in this ratio may exacerbate apoptosis, and
increasing this ratio may reverse the deleterious effect of
cytotoxic stimuli.
The finding of alterations in cytochrome c, Bax and
Bcl-2 in the present study raises the question as to whether
the mitochondria or endoplasmic reticulum trigger apoptosis. Recent evidence now implicates the endoplasmic
reticulum in this cell death pathway (for a review see Ref.
[23]). In a recent paper, it has been demonstrated that
cross-talk between mitochondria and endoplasmic reticulum is controlled by Bcl-2 [8]. Moreover, Bcl-2 is
suggested to exert its anti-apoptotic effect by maintaining
calcium homeostasis in the endoplasmic reticulum [9].
In conclusion, we have shown that Al maltolate induces
cytochrome c release and caspase-3 activation in young
adult rabbits. These effects are accompanied by a decrease
of the anti-apoptotic Bcl-2 and an increase in the proapoptotic Bax in the endoplasmic reticulum, but the
mechanism by which Al maltolate triggers these changes
remains to be determined. Furthermore, whether cytochrome c release from mitochondria precedes changes in
Bcl-2 and Bax in the endoplasmic reticulum, also remains
to be ascertained. Nevertheless, our results demonstrate
that in young adult rabbit brain, Al is able to trigger
apoptosis via its action as a neurotoxin.
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